SHANGHAI, China – At the 8th China International Import Expo (CIIE), German premium health brand MOSLATE formally announced a strategic collaboration with Aker BioMarine, a global leader in marine nutrition. The partnership was solidified with a signing ceremony at the National Exhibition and Convention Center, accompanied by the global debut of MOSLATE’s new generation Algal Oil DHA product.
Strategic Alignment on a Global Stage
The 2025 CIIE served as the backdrop for this cross-border alliance. MOSLATE attended the expo with its core R&D team, signaling a strong commitment to the Chinese market and the expo’s theme of "Global Sharing and Open Cooperation." The event provided a platform for MOSLATE to integrate global health resources and demonstrate its "pharmaceutical-grade" professional capabilities to international distributors and consumers.
Product Innovation: The "Synergistic" Approach to Cognitive Health
The highlight of the exhibition was the launch of MOSLATE’s new Algal Oil DHA Softgels. Addressing the growing consumer demand for plant-based omega-3s, the product utilizes raw materials sourced from Aker BioMarine’s Norwegian facilities. These materials are noted for their superior safety profile and sustainability, performing exceptionally well in screenings for heavy metals and microplastics.
Key product differentiators include:
High Potency: The softgels contain a 70% concentration of Algal Oil DHA, approximately double the content found in standard market alternatives.
Synergistic Formulation: MOSLATE introduced a "Golden Pair" formula combining Phosphatidylserine (PS) with DHA. This dual-action complex is designed to enhance signal transmission between nerve cells, aiming to improve memory, alleviate cognitive and visual fatigue, and support mood balance. The product targets the specific needs of adolescents and aging populations facing cognitive decline.
Merging Heritage with Marine Tech
The collaboration represents a significant step in MOSLATE’s strategy of "Global Quality Resource Integration." By combining the 120-year pharmaceutical heritage of MOSLATE’s founding Doerr family with Aker BioMarine’s technological advantages in marine raw materials, the two companies aim to co-develop safer and more efficient nutritional solutions.
"The CIIE acts as a 'magnetic field' for global cooperation," stated a MOSLATE representative. "This partnership allows us to leverage Aker’s technical prowess to continue optimizing our product matrix and provide high-quality health protection for consumers worldwide".
About MOSLATE
MOSLATE is a German health brand rooted in a century-old pharmaceutical tradition. Committed to scientific rigor, the brand provides precise, safe, and efficient nutritional solutions to consumers globally.
© OfficialAffairs
